1. Home
  2. PSTV vs CISO Comparison

PSTV vs CISO Comparison

Compare PSTV & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • CISO
  • Stock Information
  • Founded
  • PSTV 1996
  • CISO 2015
  • Country
  • PSTV United States
  • CISO United States
  • Employees
  • PSTV N/A
  • CISO N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • CISO Computer Software: Prepackaged Software
  • Sector
  • PSTV Health Care
  • CISO Technology
  • Exchange
  • PSTV Nasdaq
  • CISO Nasdaq
  • Market Cap
  • PSTV 8.6M
  • CISO 8.0M
  • IPO Year
  • PSTV N/A
  • CISO N/A
  • Fundamental
  • Price
  • PSTV $1.82
  • CISO $0.61
  • Analyst Decision
  • PSTV Strong Buy
  • CISO
  • Analyst Count
  • PSTV 1
  • CISO 0
  • Target Price
  • PSTV $8.00
  • CISO N/A
  • AVG Volume (30 Days)
  • PSTV 41.1K
  • CISO 99.0K
  • Earning Date
  • PSTV 08-12-2024
  • CISO 08-07-2024
  • Dividend Yield
  • PSTV N/A
  • CISO N/A
  • EPS Growth
  • PSTV N/A
  • CISO N/A
  • EPS
  • PSTV N/A
  • CISO N/A
  • Revenue
  • PSTV $6,084,000.00
  • CISO $55,165,412.00
  • Revenue This Year
  • PSTV $5.21
  • CISO $78.76
  • Revenue Next Year
  • PSTV N/A
  • CISO N/A
  • P/E Ratio
  • PSTV N/A
  • CISO N/A
  • Revenue Growth
  • PSTV 733.42
  • CISO 8.28
  • 52 Week Low
  • PSTV $0.97
  • CISO $0.54
  • 52 Week High
  • PSTV $3.21
  • CISO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 51.37
  • CISO 39.82
  • Support Level
  • PSTV $1.40
  • CISO $0.54
  • Resistance Level
  • PSTV $1.59
  • CISO $0.64
  • Average True Range (ATR)
  • PSTV 0.16
  • CISO 0.05
  • MACD
  • PSTV 0.04
  • CISO 0.01
  • Stochastic Oscillator
  • PSTV 78.15
  • CISO 39.44

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: